Grufity logoGrufity logo

908 Devices Inc. Stock Research

MASS

8.94USD+0.68(+8.23%)Market Closed

Market Summary

USD8.94+0.68
Market Closed
8.23%

MASS Alerts

MASS Stock Price

MASS RSI Chart

MASS Valuation

Market Cap

283.0M

Price/Earnings (Trailing)

-10.38

Price/Sales (Trailing)

5.54

Price/Free Cashflow

-10.67

MASS Price/Sales (Trailing)

MASS Profitability

Operating Margin

57.27%

Return on Equity

-13.88%

Return on Assets

-10.94%

Free Cashflow Yield

-9.37%

MASS Fundamentals

MASS Revenue

Revenue (TTM)

51.0M

Revenue Y/Y

25.92%

Revenue Q/Q

42.24%

MASS Earnings

Earnings (TTM)

-27.3M

Earnings Y/Y

-20.71%

Earnings Q/Q

22.72%

Price Action

52 Week Range

6.8726.00
(Low)(High)

Last 7 days

-0.7%

Last 30 days

-13.7%

Last 90 days

3%

Trailing 12 Months

-47.2%

MASS Financial Health

Current Ratio

11.74

MASS Investor Care

Shares Dilution (1Y)

14.23%

Diluted EPS (TTM)

-0.87

Financials for 908 Devices

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue6.8%51.0048.0045.0042.0032.00
Gross Profit9.5%29.0027.0024.0023.0017.00
Operating Expenses8.2%58.0053.0050.0045.0039.00
  S&GA Expenses8.0%41.0038.0036.0032.0028.00
  R&D Expenses8.9%17.0015.0014.0013.0012.00
Interest Expenses1.9%0.000.000.000.001.00
Net Income-4.1%-27.27-26.19-25.52-22.20-28.91
Net Income Margin2.4%-0.53*-0.55*-0.57*-0.53*-
Free Cahsflow-11.3%-26.52-23.82-21.26-29.82-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets0.9%249247251261166
  Current Assets-6.2%224239243253157
    Cash Equivalents-9.1%194213223224139
  Inventory4.9%12.0011.0010.008.008.00
  Net PPE14.1%3.002.002.002.002.00
  Goodwill-9.00----
Liabilities15.0%53.0046.0044.0046.0044.00
  Current Liabilities23.6%19.0015.0014.0015.0013.00
    LT Debt, Non Current0%15.0015.0015.0015.0015.00
Shareholder's Equity-2.3%197201207215123
  Retained Earnings-5.2%-124-118-110-100-97.17
  Additional Paid-In Capital0.7%321319317315220
Shares Outstanding0.4%32.0032.0031.0031.0028.00
Cashflow (Last 12 Months)
(In Thousands)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-8.7%-25,034-23,020-19,915-29,082-17,530
  Share Based Compensation24.8%6,0764,8673,4542,5041,938
Cashflow From Investing-1803.7%-15,249-801-1,345-737-683
Cashflow From Financing-0.3%95,30095,61295,42194,725137,376

Risks for MASS

What is the probability of a big loss on MASS?

97.5%


Probability that 908 Devices stock will be more than 20% underwater in next one year

90.7%


Probability that 908 Devices stock will be more than 30% underwater in next one year.

90.7%


Probability that 908 Devices stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MASS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if 908 Devices was unfortunately bought at previous high price.

Drawdowns

Returns for MASS

Cumulative Returns on MASS

Which funds bought or sold MASS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
BAILLIE GIFFORD & CO
unchanged
-
-2,103
1,897
-%
2023-03-06
Rockefeller Capital Management L.P.
new
-
48,000
48,000
-%
2023-02-17
TRUIST FINANCIAL CORP
reduced
-21.15
-143,559
82,441
-%
2023-02-15
Metropolitan Life Insurance Co/NY
unchanged
-
-13,027
10,973
-%
2023-02-15
Bruce & Co., Inc.
new
-
520,339
520,339
0.13%
2023-02-15
MetLife Investment Management, LLC
unchanged
-
-105,636
91,364
-%
2023-02-15
ALLIANCEBERNSTEIN L.P.
added
32.89
-94,124
150,876
-%
2023-02-15
Belvedere Trading LLC
new
-
78,760
78,760
-%
2023-02-14
Graham Capital Management, L.P.
new
-
100,187
100,187
-%
2023-02-14
MILLENNIUM MANAGEMENT LLC
reduced
-60.53
-5,628,000
1,260,000
-%

1–10 of 46

Latest Funds Activity

Are funds buying MASS calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own MASS
No. of Funds

908 Devices News

MarketBeat

Q1 2023 EPS Estimates for 908 Devices Inc. (NASDAQ:MASS ....

MarketBeat,
5 days ago

Marketscreener.com

Seeking Alpha

Schedule 13G FIlings of 908 Devices

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
alger associates inc
8.8%
2,805,216
SC 13G/A
Feb 14, 2023
eventide asset management, llc
7.0%
2,230,665
SC 13G
Feb 13, 2023
arch venture fund vii, l.p.
18.1%
5,725,045
SC 13G/A
Feb 01, 2023
blackrock inc.
5.6%
1,763,507
SC 13G/A
Jul 08, 2022
blackrock inc.
7.4%
2,318,894
SC 13G
Feb 09, 2022
ark investment management llc
9.66%
2,996,393
SC 13G/A
Feb 08, 2022
arch venture fund vii, l.p.
18.5%
5,725,045
SC 13G/A

MASS Fair Value

Recent SEC filings of 908 Devices

View All Filings
Date Filed Form Type Document
Mar 15, 2023
10-K
Annual Report
Mar 15, 2023
S-8
Employee Benefits Plan
Mar 07, 2023
4
Insider Trading
Mar 07, 2023
8-K
Current Report
Feb 23, 2023
4
Insider Trading
Feb 23, 2023
4
Insider Trading
Feb 17, 2023
4
Insider Trading
Feb 14, 2023
5
Insider Trading
Feb 14, 2023
SC 13G
Major Ownership Report
Feb 14, 2023
SC 13G/A
Major Ownership Report

Latest Insider Trading transactions for MASS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-02
Hunt Anthony
acquired
-
-
2,058
-
2023-02-22
ELOI FENEL M
acquired
-
-
507
-
2023-02-22
George Jeffrey P.
acquired
-
-
507
-
2023-02-16
Knopp Kevin J.
sold
-49,001
10.12
-4,842
president and ceo
2023-02-15
Knopp Kevin J.
sold
-155,976
10.29
-15,158
president and ceo
2023-02-02
Knopp Kevin J.
sold
-420,400
10.51
-40,000
president and ceo
2023-02-02
Griffith Joseph H. IV
sold
-32,758
10.03
-3,266
chief financial officer
2023-02-02
Turner Michael S.
sold
-28,537
10.02
-2,848
vp, general counsel
2023-02-02
Brown Christopher D.
sold
-100,300
10.03
-10,000
chief technology officer
2023-02-01
Fitzpatrick Maura
acquired
-
-
4,427
vp, product management & mktg

1–10 of 50

Kevin J. Knopp
60
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

MASS Income Statement

2022-09-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue$ 15,797$ 12,545$ 35,209$ 26,365
Cost of revenue6,4595,73315,10812,266
Gross profit9,3386,81220,10114,099
Operating expenses:    
Research and development4,6663,30212,8649,322
Selling, general and administrative11,8268,78632,28123,318
Total operating expenses16,49212,08845,14532,640
Loss from operations(7,154)(5,276)(25,044)(18,541)
Other income (expense):    
Interest expense(33)(31)(68)(446)
Other income, net9281221,340283
Total other income (expense), net895911,272(163)
Net loss$ (6,259)$ (5,185)$ (23,772)$ (18,704)
Net loss per share, basic$ (0.20)$ (0.19)$ (0.76)$ (0.68)
Net loss per share, diluted$ (0.20)$ (0.19)$ (0.76)$ (0.68)
Weighted average common shares outstanding, basic31,606,48427,707,85831,441,61127,446,149
Weighted average common shares outstanding, diluted31,606,48427,707,85831,441,61127,446,149
Product and service revenue    
Revenue$ 15,437$ 12,285$ 34,074$ 25,557
Cost of revenue6,3665,65614,76812,062
License and contract revenue    
Revenue3602601,135808
Cost of revenue$ 93$ 77$ 340$ 204

MASS Balance Sheet

2022-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 193,698$ 224,073
Accounts receivable, net of allowance for doubtful accounts of $1,75015,23116,375
Inventory11,7317,918
Prepaid expenses and other current assets3,2224,527
Total current assets223,882252,893
Operating lease, right-of-use assets4,2715,182
Property and equipment, net2,7611,603
Goodwill9,200 
Intangible assets, net7,969 
Other long-term assets1,1981,228
Total assets249,281260,906
Current liabilities:  
Accounts payable1,6631,371
Accrued expenses8,5646,961
Deferred revenue7,4195,160
Operating lease liabilities1,4321,344
Total current liabilities19,07814,836
Long-term debt15,00015,000
Operating lease liabilities, net of current portion3,4294,508
Deferred revenue, net of current portion12,16211,958
Deferred income taxes2,570 
Other long-term liabilities542 
Total liabilities52,78146,302
Commitments and contingencies (Note 10)
Stockholders' equity:  
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued or outstanding at September 30, 2022 and December 31, 2021, respectively
Common stock, $0.001 par value; 100,000,000 shares authorized; 31,652,058 shares and 31,077,004 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively3231
Additional paid-in capital321,491315,210
Accumulated other comprehensive loss(613) 
Accumulated deficit(124,410)(100,637)
Total stockholders' equity196,500214,604
Total liabilities and stockholders' equity$ 249,281$ 260,906